The Lancet Gastroenterology & Hepatology in conversation with
En podkast av The Lancet Group
88 Episoder
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publisert: 9.9.2021 -
Raymond Henderson on the economic burden of colorectal cancer
Publisert: 12.8.2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publisert: 22.6.2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publisert: 3.6.2021 -
Matthew Akiyama on hepatitis C in prisons
Publisert: 12.4.2021 -
Monika Sarkar on reproductive health in women with liver disease
Publisert: 11.3.2021 -
Colorectal cancer risk in patients with Crohn’s disease
Publisert: 12.3.2020 -
Liver damage in young adults
Publisert: 17.1.2020 -
Treatments for IBS
Publisert: 14.1.2020 -
Statins and decompensated cirrhosis
Publisert: 27.11.2019 -
Global burden of pancreatic cancer and colorectal cancer
Publisert: 4.11.2019 -
Paediatric inflammatory bowel disease
Publisert: 12.9.2019 -
Transplanting hepatitis C-infected hearts
Publisert: 28.8.2019 -
Primary anastomosis as a treatment for diverticulitis
Publisert: 31.7.2019 -
Faecal microbiota transplantation in IBS
Publisert: 30.7.2019 -
Treating faecal incontinence in women
Publisert: 17.7.2019 -
Viral hepatitis in children & adolescents
Publisert: 23.5.2019 -
Whole-body MRI: the STREAMLINE trials
Publisert: 11.5.2019 -
A new drug for short bowel syndrome
Publisert: 5.4.2019 -
Eosinophilic oesophagitis endotype classification
Publisert: 9.3.2019
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
